Dr. Michael L. Cheng is a medical oncologist who cares for patients with lung cancer and other tumors affecting the lungs, with a particular focus on non-small cell lung cancer. He strives to provide individualized, compassionate care through precision oncology (using the patient's genetic profile to custom-tailor treatment).
Cheng leads research centered on advancing cancer genomics and developing improved treatments for patients, including through clinical trials to evaluate new targeted therapies and immunotherapies for lung cancer. He is inspired by how research discoveries can lead to tangible benefits for patients.
Cheng earned his medical degree from the David Geffen School of Medicine at UCLA. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Memorial Sloan Kettering Cancer Center. Before joining the UCSF faculty, he served as an assistant professor at the Dana-Farber Cancer Institute and Harvard Medical School.
Cheng is a member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research and International Association for the Study of Lung Cancer. He has received the Career Development Award from Conquer Cancer, the ASCO Foundation.
